Recombinant pharmaceuticals from plants: the plant endomembrane system as bioreactor

Mol Interv. 2005 Aug;5(4):216-25. doi: 10.1124/mi.5.4.5.

Abstract

The production of safe pharmaceuticals at affordable costs is one of the great challenges of our times. Research has proven that transgenic plants can fulfill this need. This review focuses on the peculiar features of plant cells that allow high accumulation of recombinant proteins. The endomembrane system and the secretory pathway of plant cells in themselves offer a fascinating model of protein sorting, and in practical terms, represent the potential for the facile and very low-cost purification of recombinant pharmaceutical proteins.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Bioreactors*
  • Biotechnology / methods
  • Endoplasmic Reticulum / metabolism*
  • Endoplasmic Reticulum / ultrastructure
  • Humans
  • Plant Cells
  • Plant Proteins* / genetics
  • Plant Proteins* / metabolism
  • Plant Proteins* / therapeutic use
  • Plants* / metabolism
  • Recombinant Proteins* / genetics
  • Recombinant Proteins* / metabolism
  • Recombinant Proteins* / therapeutic use
  • Vacuoles / metabolism*
  • Vacuoles / ultrastructure

Substances

  • Plant Proteins
  • Recombinant Proteins